Zojwalla Naseem

Companies where Zojwalla Naseem has traded

• Olema Pharmaceuticals, Inc.36 tx · $10M · Feb 4, 2026

Track record of Zojwalla Naseem

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Zojwalla Naseem

Co-insiders of Zojwalla Naseem

• Asefaw SenaiOlema Pharmaceuticals, Inc.
• Austin Sasha LuOlema Pharmaceuticals, Inc.
• Bain Capital Life Sciences Fund IV, L.P.Olema Pharmaceuticals, Inc.
• Bain Capital Life Sciences Investors, LLCOlema Pharmaceuticals, Inc.
• Bain Capital Life Sciences IV General Partner, LLCOlema Pharmaceuticals, Inc.
• Bain Capital Life Sciences Opportunities IV GP, LLCOlema Pharmaceuticals, Inc.
• Bain Capital Life Sciences Opportunities IV, L.P.Olema Pharmaceuticals, Inc.
• BIOTECHNOLOGY VALUE FUND II LPOlema Pharmaceuticals, Inc.
• BIOTECHNOLOGY VALUE FUND L POlema Pharmaceuticals, Inc.
• Biotechnology Value Trading Fund OS LPOlema Pharmaceuticals, Inc.
• Bohen SeanOlema Pharmaceuticals, Inc.
• BUTITTA CYNTHIA MOlema Pharmaceuticals, Inc.
• BVF GP HOLDINGS LLCOlema Pharmaceuticals, Inc.
• BVF I GP LLCOlema Pharmaceuticals, Inc.
• BVF II GP LLCOlema Pharmaceuticals, Inc.
• BVF INC/ILOlema Pharmaceuticals, Inc.
• BVF PARTNERS L P/ILOlema Pharmaceuticals, Inc.
• BVF Partners OS Ltd.Olema Pharmaceuticals, Inc.
• Chen BihuaOlema Pharmaceuticals, Inc.
• CLARK IAN TOlema Pharmaceuticals, Inc.
• Cormorant Asset Management, LPOlema Pharmaceuticals, Inc.
• Cormorant Global Healthcare Master Fund, LPOlema Pharmaceuticals, Inc.
• Cormorant Private Healthcare Fund III LPOlema Pharmaceuticals, Inc.
• Cormorant Private Healthcare Fund II, LPOlema Pharmaceuticals, Inc.
• Garland J. ScottOlema Pharmaceuticals, Inc.
• Graham G. WalmsleyOlema Pharmaceuticals, Inc.
• Harmon CyrusOlema Pharmaceuticals, Inc.
• Horning SandraOlema Pharmaceuticals, Inc.
• Horn KinneyOlema Pharmaceuticals, Inc.
• Hrustanovic GorjanOlema Pharmaceuticals, Inc.
• Kovacs Shane William CharlesOlema Pharmaceuticals, Inc.
• Kushner Peter J.Olema Pharmaceuticals, Inc.